Technical Analysis for REDX - Redx Pharma Plc

Grade Last Price % Change Price Change
grade B 14.5 0.00% 0.00
REDX closed unchanged on Tuesday, May 26, 2020, on 4 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical REDX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Redx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The Company is engaged in drug discovery across cancer, infection and autoimmune diseases. The Company has over two programs in its oncology research activity, Smoothened Hedgehog (SMO) and Bruton's Tyrosine Kinase (BTK), which has reached candidate nomination stage. The Company's oncology research activity also include Porcupine program, Colony Stimulating Factor-1 receptor (CSF-1) program, Indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibitor and Pan-Raf inhibitor. The Company's anti-infective candidate compound is an antibiotic that the Company has developed to treat a range of Gram-positive bacterial infections, including resistant strains, such as Methicillin-Resistant Staphylococcus Aureus (MRSA). Its product candidate, RDX003, is a class of antibiotic acting through the type II bacterial topoisomerases. It is also evaluating BTK inhibitor for immunological disorders.
Branches Of Biology Medical Specialties Cancer Drug Discovery Autoimmune Diseases Infectious Diseases Infection Antibiotic Bacterial Diseases Healthcare Associated Infections Staphylococcus Aureus

Is REDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 15.95
52 Week Low 4.5
Average Volume 506,009
200-Day Moving Average 9.51
50-Day Moving Average 13.44
20-Day Moving Average 12.96
10-Day Moving Average 11.45
Average True Range 1.31
ADX 39.23
+DI 25.81
-DI 15.15
Chandelier Exit (Long, 3 ATRs ) 11.83
Chandelier Exit (Short, 3 ATRs ) 13.19
Upper Bollinger Band 17.34
Lower Bollinger Band 8.58
Percent B (%b) 0.68
BandWidth 67.63
MACD Line -0.28
MACD Signal Line -0.52
MACD Histogram 0.2388
Fundamentals Value
Market Cap 7.4 Million
Num Shares 510 Thousand
EPS -0.10
Price-to-Earnings (P/E) Ratio -145.00
Price-to-Sales 0.00
Price-to-Book 277.55
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.50
Resistance 3 (R3) 14.50 14.50 14.50
Resistance 2 (R2) 14.50 14.50 14.50 14.50
Resistance 1 (R1) 14.50 14.50 14.50 14.50 14.50
Pivot Point 14.50 14.50 14.50 14.50 14.50
Support 1 (S1) 14.50 14.50 14.50 14.50 14.50
Support 2 (S2) 14.50 14.50 14.50 14.50
Support 3 (S3) 14.50 14.50 14.50
Support 4 (S4) 14.50